Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Do Not Tube List
Webpage Links
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

Belbuca

buprenorphine
Brand names: Belbuca, Buprenex, Butrans Transdermal System (non-formulary), Sublocade
Form Strength
FILM, BUCCAL Belbuca (buccal film of choice for formulary)
FILM, EXTENDED RELEASE, TRANSDERMAL 10 mcg/hr
SOLUTION, EXTENDED RELEASE, SUBCUTANEOUS 300 mg/1.5 mL
SOLUTION, INJECTABLE 0.3 mg/mL
TABLET, SUBLINGUAL 2 mg; 8 mg
VIEW MORE Opioid Partial Agonists
CLASS
280812
Additional Information:

Management of Opioid Use Disorder: See Practice Guideline 900.5034

Buprenorphine Patch (Butrans) is NON-formulary as of 2017

Buprenorphine extended‐release (SUBLOCADE®) is Restricted as below:

    • Ambulatory:  For clinics (typically primary care, Pain Clinics and Project Nurture); due to REMS program, only to be filled through Legacy Apothecary. 
    • Inpatient: Non-formulary
Drug Name Common Side Effects

Buprenorphine
  • sedation
  • dizziness, headache
  • nausea, vomiting

 

Last updated: Jun. 6, 2024
Class III






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved